Trial intelligence / Profile preview

MUA with Dexamethasone and Celecoxib for TKA Stiffness

NCT02739035Phase 4Completed

Sponsor
Mayo Clinic
Start
Apr 2016
Primary completion
Dec 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial of celecoxib and dexamethasone (2 arms), sponsored by Mayo Clinic. Primary endpoint: Knee Range of Motion After Manipulation Under Anesthesia at 1 year. Started Apr 2016; status: completed.

02

Drugs

celecoxibdexamethasone

Beyond the preview

Go deeper on NCT02739035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02739035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call